TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 25151031

Group type: EXPERIMENTAL
Intervention: STAT: simvastatin, 40 mg/day
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: EX: brisk walking and/or slow jogging, 45 minutes/day, 5 days/week
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: STAT + EX
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 50
Study: 22822453

Group type: EXPERIMENTAL
Intervention: Milk chocolate snack
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Dark chocolate
Number of subjects: 90

Group type: COMPARATOR
Intervention: Crackers with cheese spread (control)
Number of subjects: 90
Study: 20228381

Group type: EXPERIMENTAL
Intervention: Sildenafil (25 or 100 mg)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 17388768

Group type: EXPERIMENTAL
Intervention: Aromatherapy acupressure
Number of subjects: 30

Group type: COMPARATOR
Intervention: Acupressure
Number of subjects: 30
Study: 16254086

Group type: EXPERIMENTAL
Intervention: Intergroup interaction
Number of subjects: 0

Group type: COMPARATOR
Intervention: Within-group interaction
Number of subjects: 0
Study: 12148173

Group type: EXPERIMENTAL
Intervention: Triamcinolone (200 mcg twice daily)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Nedocromil (0.004 g four times daily)
Number of subjects: 37
Study: 10577402

Group type: EXPERIMENTAL
Intervention: Video self-instruction (VSI) in CPR for 34 minutes
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional CPR training (4-hour American Heart Association 'Heartsaver' CPR course)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Video self-instruction (VSI)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional CPR training
Number of subjects: 0
Study: 8538079

Group type: EXPERIMENTAL
Intervention: Kanji morphogram reading
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Kana syllabogram reading
Number of subjects: 9

Group type: COMPARATOR
Intervention: Eyes open controls
Number of subjects: 9
Study: 2015731

Group type: EXPERIMENTAL
Intervention: Fluconazole, 200 mg orally, daily for 14 days
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 7278648

Group type: EXPERIMENTAL
Intervention: Mazindol (1 mg, TID, po)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31241782

Group type: EXPERIMENTAL
Intervention: Static computer‐assisted implant surgery (CAIS)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Freehand implant surgery
Number of subjects: 52
Study: 27686365

Group type: EXPERIMENTAL
Intervention: Observational treatment strategy
Number of subjects: 528

Group type: COMPARATOR
Intervention: Antibiotic treatment strategy
Number of subjects: 528
Study: 26743237

Group type: EXPERIMENTAL
Intervention: High-rate cut-off programming (Arm B)
Number of subjects: 1499

Group type: EXPERIMENTAL
Intervention: Delayed ventricular tachycardia therapy programming (Arm C)
Number of subjects: 1499

Group type: COMPARATOR
Intervention: CRT-D patients
Number of subjects: 1499

Group type: COMPARATOR
Intervention: Both groups (ICD and CRT-D)
Number of subjects: 1499
Study: 24150522

Group type: EXPERIMENTAL
Intervention: Liver resection
Number of subjects: 52

Group type: COMPARATOR
Intervention: Radiofrequency ablation (RFA)
Number of subjects: 52

Group type: COMPARATOR
Intervention: RFA
Number of subjects: 52
Study: 22082694

Group type: EXPERIMENTAL
Intervention: Tetracaine HCl
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Proparacaine HCl
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: TetraVisc
Number of subjects: 60
Study: 18767129

Group type: EXPERIMENTAL
Intervention: Proactive recruitment (face‐to‐face)
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: Reactive recruitment (television, radio, or newspaper ads)
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: Combination recruitment (both reactive and proactive)
Number of subjects: 249
Study: 17660602

Group type: EXPERIMENTAL
Intervention: Granulocyte colony-stimulating factor (G-CSF, or filgrastim) 300 mcg s/c weekly
Number of subjects: 47

Group type: COMPARATOR
Intervention: Interferon dose reduction or temporary inhibition of Interferon treatment
Number of subjects: 47
Study: 15876831

Group type: EXPERIMENTAL
Intervention: High-flux membranes
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional low-flux dialysis
Number of subjects: 0
Study: 11988189

Group type: EXPERIMENTAL
Intervention: Brachial artery wall thickness (WT) in patients with CAD (0.4 +/- 0.05 mm)
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: Brachial artery wall index (WI) in patients with CAD (16.1 +/- 0.0)
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: WT and WI correlation with CAD presence
Number of subjects: 179
Study: 9607671

Group type: EXPERIMENTAL
Intervention: Functional brace
Number of subjects: 85

Group type: COMPARATOR
Intervention: Dorso‐ulnar plaster‐of‐Paris
Number of subjects: 85

Group type: COMPARATOR
Intervention: Elastic bandage
Number of subjects: 85
Study: 8151107

Group type: EXPERIMENTAL
Intervention: UDCA (600 mg/day)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 3524728

Group type: EXPERIMENTAL
Intervention: Sulphamethoxazole 2 g daily for 3 months
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study: 26672090

Group type: EXPERIMENTAL
Intervention: HbSS (Walk‐PHaSST Trial)
Number of subjects: 463

Group type: COMPARATOR
Intervention: HbSC (Walk‐PHaSST Trial)
Number of subjects: 463

Group type: COMPARATOR
Intervention: CSSCD
Number of subjects: 463
Study: 25230733

Group type: EXPERIMENTAL
Intervention: Low-dose aspirin combined with Tiao Jing Cu Yun pills
Number of subjects: 78

Group type: COMPARATOR
Intervention: Letrozole alone (Control)
Number of subjects: 78
Study: 22169113

Group type: EXPERIMENTAL
Intervention: MBX-8025 (50 mg/d)
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: MBX-8025 (100 mg/d)
Number of subjects: 166

Group type: COMPARATOR
Intervention: Atorvastatin (20 mg/d)
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: MBX-8025 (100 mg/d) + Atorvastatin (20 mg/d)
Number of subjects: 166
Study: 20307706

Group type: COMPARATOR
Intervention: mebeverine
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: mebeverine+CBT
Number of subjects: 149
Study: 17942379

Group type: EXPERIMENTAL
Intervention: Various interventions from randomized controlled clinical trials on GERD
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Therapies evaluated in trials
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Follow-up data
Number of subjects: 0
Study: 16254540

Group type: EXPERIMENTAL
Intervention: Enhanced intervention group
Number of subjects: 427

Group type: COMPARATOR
Intervention: Basic group
Number of subjects: 427
Study: 11903465

Group type: EXPERIMENTAL
Intervention: Phenytoin (PHT) administered at 18 mg/kg as an intravenous intraoperative load, followed by daily doses to maintain serum PHT concentrations within the 10-20 aeg/ml range for 7 days.
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group (no PHT administered).
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Phenytoin (PHT) group.
Number of subjects: 200
Study: 11783155

Group type: EXPERIMENTAL
Intervention: Shenmai injection (SMI) combined with western medicine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Western medicine alone (Control)
Number of subjects: 60
Study: 7861515

Group type: EXPERIMENTAL
Intervention: Laparoscopic lymphocelectomy (group 1)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Open lymphocelectomy (group 2)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Historical open lymphocelectomy (group 3)
Number of subjects: 38
Study: 1827810

Group type: EXPERIMENTAL
Intervention: diatrizoate (ionic, high osmolality)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: ioxaglate (ionic, low osmolality)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: iohexol (nonionic, low osmolality)
Number of subjects: 30
Study: 7001242

Group type: EXPERIMENTAL
Intervention: Diethylstilbestrol (DES)
Number of subjects: 143

Group type: COMPARATOR
Intervention: Tamoxifen
Number of subjects: 143
Study: 31133672

Group type: EXPERIMENTAL
Intervention: Intermittent screening and treatment with dihydroartemisinin-piperaquine (IST-DP)
Number of subjects: 681

Group type: COMPARATOR
Intervention: Intermittent preventive therapy with sulfadoxine-pyrimethamine (IPT-SP)
Number of subjects: 681
Study: 28410008

Group type: EXPERIMENTAL
Intervention: Stepwise carious tissue removal
Number of subjects: 239

Group type: COMPARATOR
Intervention: Nonselective carious removal to hard dentin
Number of subjects: 239

Group type: COMPARATOR
Intervention: Conventional pulp-capping procedures (direct pulp capping or partial pulpotomy)
Number of subjects: 239
Study: 26393848

Group type: EXPERIMENTAL
Intervention: Lifestyle-focused text messaging (4 messages/week for 6 months)
Number of subjects: 710

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 710
Study: 24195872

Group type: EXPERIMENTAL
Intervention: APAP treatment for 2 or 3 preoperative nights and 5 postoperative nights.
Number of subjects: 177

Group type: COMPARATOR
Intervention: Control group receiving routine care.
Number of subjects: 177
Study: 21208974

Group type: EXPERIMENTAL
Intervention: RLY5016 (30 g/day)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: RLY5016 (30 g/day) in patients with CKD
Number of subjects: 105

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 105
Study: 19844579

Group type: EXPERIMENTAL
Intervention: Intervention program aimed at health promotion or disease prevention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 17900336

Group type: EXPERIMENTAL
Intervention: Cognitive behavioural group intervention (8 weekly sessions of 2 hours each, plus a booster session after 6 months)
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Cognitive behavioural group intervention
Number of subjects: 168
Study: 15021192

Group type: EXPERIMENTAL
Intervention: Indomethacin for the prevention and treatment of patent ductus arteriosus
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pharmacologic or surgical methods to close the ductus arteriosus
Number of subjects: 0
Study: 11899912

Group type: EXPERIMENTAL
Intervention: 1.0 microg/cm2 of TGF‐beta3
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: 2.5 microg/cm2 of TGF‐beta3
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 14
Study: 9764446

Group type: EXPERIMENTAL
Intervention: Walking training (65-75% of VO2max, 50 min/session, four times a week for 15 weeks)
Number of subjects: 119

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 119
Study: 10163540

Group type: EXPERIMENTAL
Intervention: Multiple donor non‐apheresis buffy coat platelets (BCP)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Single donor apheresis platelets (SDP)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Single donor leucodepleted SDP (LD‐SDP)
Number of subjects: 0
Study: 2655452

Group type: EXPERIMENTAL
Intervention: Triphasil (ethinyl estradiol/levonorgestrel)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ortho‐Novum 7/7/7 (ethinyl estradiol/norethindrone)
Number of subjects: 0
Study: 826928

Group type: EXPERIMENTAL
Intervention: Group M-P (no undrugged practice before marijuana intoxication)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Group P-M (undrugged practice before marijuana intoxication)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Control measures (pulse rate, salivary flow, subjective responses)
Number of subjects: 2
Study: 31895058

Group type: EXPERIMENTAL
Intervention: Virtual reality-based treatment
Number of subjects: 19

Group type: COMPARATOR
Intervention: Cognitive-behavioral usual treatment
Number of subjects: 19
Study: 31518058

Group type: EXPERIMENTAL
Intervention: Same-day ART initiation
Number of subjects: 536
Study: 28221060

Group type: EXPERIMENTAL
Intervention: Challenging Horizons Program (CHP) - yearlong afterschool program
Number of subjects: 216

Group type: COMPARATOR
Intervention: Comparable control participants (community care)
Number of subjects: 216
Study: 25176010

Group type: EXPERIMENTAL
Intervention: n-3 PUFA supplementation (1.3 g twice daily for 3 weeks)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: n-3 PUFA supplementation
Number of subjects: 13
Study: 23674344

Group type: EXPERIMENTAL
Intervention: Telomere length (continuous variable, reported per 0.2 unit increase)
Number of subjects: 853
Study: 21429226

Group type: EXPERIMENTAL
Intervention: Non-professional mentor support (weekly home visiting for 12 months)
Number of subjects: 215
Study: 19646193

Group type: EXPERIMENTAL
Intervention: Grape seed extract (600 mg/day)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 19280386

Group type: EXPERIMENTAL
Intervention: Employed women (hired group)
Number of subjects: 736

Group type: COMPARATOR
Intervention: Not hired women (control group)
Number of subjects: 736
Study: 15473613

Group type: EXPERIMENTAL
Intervention: Method A: Seldinger guide-wire in the distal lumen
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Method B: Middle lumen filled with saline 10% fluid column
Number of subjects: 100

Group type: COMPARATOR
Intervention: Chest radiography after surgery
Number of subjects: 100
Study: 11887655

Group type: EXPERIMENTAL
Intervention: Steri‐Oss implant system
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Southern Implants system
Number of subjects: 24
Study: 9773737

Group type: EXPERIMENTAL
Intervention: Acarbose (100 mg t.i.d.)
Number of subjects: 1418

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1418
Study: 7530821

Group type: EXPERIMENTAL
Intervention: Oxy‐ or xylometazoline nasal spray for 30 days
Number of subjects: 13
Study: 3294616

Group type: EXPERIMENTAL
Intervention: 6 mg piretanide once or twice daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: 50 mg hydrochlorothiazide plus 5 mg amiloride once daily
Number of subjects: 0
Study: 29157328

Group type: EXPERIMENTAL
Intervention: Peer acceptance
Number of subjects: 273

Group type: EXPERIMENTAL
Intervention: Peer rejection
Number of subjects: 273

Group type: COMPARATOR
Intervention: Exposure to peers (neutral condition)
Number of subjects: 273
Study: 28716617

Group type: EXPERIMENTAL
Intervention: Dignity Therapy (DT)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Waitlist Dignity Therapy (WDT)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Life Review (LR)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Dignity Therapy (DT) and Waitlist Dignity Therapy (WDT)
Number of subjects: 56
Study: 25801893

Group type: EXPERIMENTAL
Intervention: Intensive regimen (IR) of cholecalcipherol (300,000 UI initial bolus followed by 50,000 UI monthly)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Standard regimen (SR) of cholecalcipherol (25,000 UI monthly)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Both regimens (IR and SR)
Number of subjects: 34
Study: 24061864

Group type: EXPERIMENTAL
Intervention: Cisplatin administered at 6:00
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cisplatin administered at 18:00
Number of subjects: 0
Study: 21568083

Group type: EXPERIMENTAL
Intervention: tibolone 2.5 mg/day
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: CCHT 2 mg estradiol plus 1 mg norethisteron acetate
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study: 19491916

Group type: EXPERIMENTAL
Intervention: L-carnitine supplement (500 mg L-carnitine per day as L-carnitine L-tartrate) (n=13)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo (n=13)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (Placebo)
Number of subjects: 26
Study: 16955313

Group type: EXPERIMENTAL
Intervention: 1-Hz rTMS
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: 5-Hz rTMS
Number of subjects: 27

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 27
Study: 15144493

Group type: EXPERIMENTAL
Intervention: Strong African American Families Program (SAAF)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control families
Number of subjects: 0
Study: 10662566

Group type: EXPERIMENTAL
Intervention: Povidone iodine (PVP-I) in scrub formulation followed by alcoholic PVP-I
Number of subjects: 44

Group type: COMPARATOR
Intervention: Chlorhexidine in scrub formulation followed by alcoholic chlorhexidine
Number of subjects: 44
Study: 9305480

Group type: EXPERIMENTAL
Intervention: Amoxycillin (1 mg b.d.) + Omeprazole (20 mg b.d.)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Amoxycillin (1 mg b.d.) + Lansoprazole (30 mg b.d.)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Amoxycillin (1 mg b.d.) + Ranitidine (300 mg b.d.)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Age > 50 years
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: H. pylori-eradicated patients
Number of subjects: 60
Study: 1410163

Group type: EXPERIMENTAL
Intervention: Mecamylamine 20 mg
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Mecamylamine 5 mg
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Mecamylamine 10 mg
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Mecamylamine (all doses)
Number of subjects: 100
Study: 3931138

Group type: EXPERIMENTAL
Intervention: Oral physostigmine at 2 mg every 2 hours
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Oral physostigmine at lower doses
Number of subjects: 8

Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 8
Study: 31882732

Group type: EXPERIMENTAL
Intervention: Citalopram
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 29999597

Group type: EXPERIMENTAL
Intervention: Physiologic saline irrigation plus oxymetazoline hydrochloride 0.05% nasal spray (saline+oxymetazoline group)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Physiologic saline irrigation (saline group)
Number of subjects: 0
Study: 26937924

Group type: EXPERIMENTAL
Intervention: Continuous intravenous infusion of DEX in Ringer solution at a rate of 0.25 μg/kg/h
Number of subjects: 75

Group type: COMPARATOR
Intervention: Continuous intravenous infusion of saline in Ringer solution
Number of subjects: 75
Study: 24517384

Group type: EXPERIMENTAL
Intervention: My Road Ahead intervention alone
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: My Road Ahead intervention plus a moderated online forum
Number of subjects: 150

Group type: COMPARATOR
Intervention: Moderated online forum alone
Number of subjects: 150
Study: 22943135

Group type: EXPERIMENTAL
Intervention: Standard branded packages
Number of subjects: 640

Group type: COMPARATOR
Intervention: Plain packaging (without brand imagery)
Number of subjects: 640

Group type: COMPARATOR
Intervention: Plain packaging without descriptors
Number of subjects: 640

Group type: EXPERIMENTAL
Intervention: Branded packs
Number of subjects: 640
Study: 19959930

Group type: EXPERIMENTAL
Intervention: Life Review intervention (4 individual sessions, structured along 14 questions)
Number of subjects: 22
Study: 17222105

Group type: EXPERIMENTAL
Intervention: Substantial recovery at day 1 (defined as 75% improvement in NIHSS)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Substantial recovery at day 7 (defined as 65% improvement in NIHSS)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Other thresholds for recovery at day 1 (>50%, 80%, 90%, 100%)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Other thresholds for recovery at day 7 (>50%, 60%, 70%, 90%, 100%)
Number of subjects: 0
Study: 14999611

Group type: EXPERIMENTAL
Intervention: T-1249 monotherapy (subcutaneous injection) at doses ranging from 6.25 to 192 mg/day for 14 days
Number of subjects: 115
Study: 12219065

Group type: EXPERIMENTAL
Intervention: LSE plus moderate-intensity PT
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: LSE plus high-intensity PT
Number of subjects: 74

Group type: COMPARATOR
Intervention: LSE
Number of subjects: 74
Study: 9839758

Group type: EXPERIMENTAL
Intervention: Donepezil 4.0 mg
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Donepezil 6.0 mg
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 8080942

Group type: EXPERIMENTAL
Intervention: Pest control operators
Number of subjects: 359

Group type: COMPARATOR
Intervention: Licensed for 10-19 years
Number of subjects: 359

Group type: COMPARATOR
Intervention: Licensed for 20 or more years
Number of subjects: 359

Group type: COMPARATOR
Intervention: Lagged years of licensure
Number of subjects: 359

Group type: COMPARATOR
Intervention: Non-pest control workers
Number of subjects: 359
Study: 2589098

Group type: EXPERIMENTAL
Intervention: Validity of the location cue
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Validity of the form cue
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control conditions
Number of subjects: 0
Study: 802925

Group type: EXPERIMENTAL
Intervention: Streptokinase
Number of subjects: 27

Group type: COMPARATOR
Intervention: Heparin
Number of subjects: 27
Study: 31303297

Group type: EXPERIMENTAL
Intervention: Provider group (report cards shared with health providers)
Number of subjects: 3133

Group type: EXPERIMENTAL
Intervention: Community group (report cards shared with community members)
Number of subjects: 3133

Group type: EXPERIMENTAL
Intervention: Provider and community group (report cards shared with both health providers and community members)
Number of subjects: 3133

Group type: COMPARATOR
Intervention: Control group (report cards not shared)
Number of subjects: 3133
Study: 28235492

Group type: EXPERIMENTAL
Intervention: Paravertebral block (Group P, n=14)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Morphine (Group M, n=16)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Paravertebral block (Group P)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Morphine (Group M)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 30
Study: 25733651

Group type: EXPERIMENTAL
Intervention: Weight Loss (WL) through caloric restriction
Number of subjects: 38

Group type: COMPARATOR
Intervention: Weight Maintenance (WM)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Weight Loss (WL)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Weight Loss (WL) and Weight Maintenance (WM)
Number of subjects: 38
Study: 23985261

Group type: EXPERIMENTAL
Intervention: Capecitabine plus thalidomide
Number of subjects: 61

Group type: COMPARATOR
Intervention: Capecitabine alone
Number of subjects: 61